from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0491/regX3

LFCtreatmentdescriptionclass of inhibitor

-0.380

Amikacinug/mL Amikacintranslation

-2.140

Cap5-10ug/mL Capreomycintranslation

-1.787

Rox10-50 ug/mL Roxithromycintranslation

-0.580

SM2-5 ug/mL Streptomycintranslation

0.417

Tet5-10 ug/mL Tetracyclinetranslation

-0.209

Rif0.2-5ug/mL Rifampicintranscription

0.323

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.840

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.424

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.412

CPZ10-50 ug/mL Chlorpromazinerespiration

0.339

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.339

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.676

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.973

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.073

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.203

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.148

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.321

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.742

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.240

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.291

KCN5-20 ug/mL Potassium cyaniderespiration

0.609

NaN30.2-2 mM Sodium aziderespiration

0.497

Nigericin50 uM Nigericinrespiration

0.004

TRC10-150 ug/mL Triclosanrespiration

-0.679

TRZ10-25 ug/mL Thioridazinerespiration

-1.454

Valinomycin0.5-10 uM Valinomycinrespiration

-1.112

ZnSO42 mM ZnSO4respiration

-0.454

menadione6-10 ug/mL Menadionerespiration

-0.196

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.413

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.009

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.361

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.706

NRP_1Non-replicating persistence stage 1dosRassociated

0.019

Amp0.2mg/mL AmpicillincellWall

-0.538

Cephalexin20-100 ug/mL CephalexincellWall

-0.613

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.445

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.438

EMB10-20 ug/mL EthambutolcellWall

0.571

Eta12-40 ug/mL EthionamidecellWall

0.740

INH0.2-0.4 ug/mL IsoniazidcellWall

0.840

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.543

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.342

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.408

BZA0.12 mg/mL BenzamidearomaticAmides

-0.456

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.252

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.062

H2O24 mM hydrogen peroxideDNAdamaging

-0.183

Levo10 ug/mL LevofloxacinDNAdamaging

0.234

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.908

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.002

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.376

UVUV-irradiationDNAdamaging

-0.930

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.279

Antimycin12.5-50 ug/mL Antimycin A?

-0.310

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.291

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.812

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.461

PA8240.2-2 ug/mL PA-824?

1.877

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.549

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.650

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.148

methoxatin10-20 ug/mL Methoxatin?